Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoHealth (GOCO) Operating Expenses (2019 - 2025)

Historic Operating Expenses for GoHealth (GOCO) over the last 7 years, with Q3 2025 value amounting to $322.1 million.

  • GoHealth's Operating Expenses rose 10010.87% to $322.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 3690.35%. This contributed to the annual value of $805.9 million for FY2024, which is 127.53% down from last year.
  • Latest data reveals that GoHealth reported Operating Expenses of $322.1 million as of Q3 2025, which was up 10010.87% from $193.4 million recorded in Q2 2025.
  • GoHealth's Operating Expenses' 5-year high stood at $872.8 million during Q4 2021, with a 5-year trough of $146.5 million in Q2 2024.
  • In the last 5 years, GoHealth's Operating Expenses had a median value of $202.8 million in 2021 and averaged $255.5 million.
  • Per our database at Business Quant, GoHealth's Operating Expenses plummeted by 7679.14% in 2022 and then skyrocketed by 10010.87% in 2025.
  • GoHealth's Operating Expenses (Quarter) stood at $872.8 million in 2021, then crashed by 76.79% to $202.6 million in 2022, then rose by 29.17% to $261.6 million in 2023, then increased by 18.05% to $308.9 million in 2024, then rose by 4.29% to $322.1 million in 2025.
  • Its Operating Expenses stands at $322.1 million for Q3 2025, versus $193.4 million for Q2 2025 and $214.3 million for Q1 2025.